The TechMed EventProgrammePersonalized medicine

Personalized medicine

The session

“A good physician treats the disease; the great physician treats the person who has the disease. One needs to construct the patient's story. And it is this story that allows making the correct diagnosis and treatment.” It is with these words that Sir William Osler, around 1870, might have first posed the challenge of an integrated approach around the patient that has later become a personalized medicine approach. Roughly 150 years after Sir William Ossler’s vision, TechMed is making a decisive step forward to becoming one of Europe’s key players in the domain of personalized medicine, thereby shaping society to fulfil this visionary physician’s quest.

Predictive, Preventive, Personalized, and Participatory medicine, or Personalized Medicine, in short, is that specific stream in medicine that considers each patient’s unique characteristics leading to a targeted health and care approach specific to the individual person. But while the term “medicine” indicates that this form of healthcare is only related to drugs, personalized medicine also sees a technological drive and will induce a transformation of how health and well-being are approached, and medicine is being implemented. With the broadening of Personalized Medicine, many new possibilities are opening up, that should be tackled, and the full potential of the use of new technologies for Personalized Medicine should be unlocked.

Where & When
  • Time: 10.00 - 12.00
  • Language: English
  • Room: INNOVATION ROOM (TL1133)
  • Seats: 100

The programme

In this session as such, we will show how technologies can provide a personalized care for patients, providing four examples. The first example will focus on technologies for women’s health and how these can be used, optimized, and personalized for women’s health, throughout their lifespan. The second example will investigate renal health, and how technologies will provide better care for patients with renal disease. Are ideas such as artificial kidneys a long-term vision or will they become reality sooner as we expect them to? Thirdly, with the rise of chronic diseases, we need to ensure that we start tackling diseases before they even occur. We will discuss the role of diabetes, and how technology will make a decisive step to returning diabetes. We will close the session by discussing the need for realistic digital and physical models of body parts and organs, for optimizing and standardizing imaging technologies and approaches for personalized health well before their use on patients, so as to accelerate clinical translation of these advances.